Skip to main content
SpringerLink
Log in

Synbiotics in Hepatocellular Carcinoma

  • Chapter
  • First Online:
Synbiotics for the Management of Cancer

  • 196 Accesses

Abstract

Cancer is a deadly disease that affect a wide range of population worldwide. It is accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The more common are breast, lung, colon and rectum, and prostate. Heterogenicity of cancers, resistance for drugs used, late diagnosis, drug resistance, late diagnosis, non-selectivity of drugs towards cancer cell are the main challenges towards the treatment of cancer. Hepatocellular carcinoma (HCC) is the cancer of liver. In early-stage diagnosis, it may be treatable by surgery, chemotherapy, radiation therapy, and targeted therapy. Once it is metastasized it is difficult to cure. The treatment is dependent on the condition of the patient and liver transplant can be performed in early stages. The adverse effects of presently available chemotherapy and radiation therapy are the main drawback for the treatment of HCC. Synbiotics are the combination of pre- and probiotics. Synbiotics have major use in effective treatment of various diseases including cardiovascular, reproductive, metabolic, neurodegenerative, gastrointestinal, thrombotic, skin, inflammatory disorders, and cancer. In recent years, synbiotics have come up as a potential therapeutic approach for the treatment of various cancers including HCC. Proper use of synbiotics have marked impact on the multiplication of beneficial microbes and these microbes have significant role in the cancer pathophysiology. Moreover, these microbes can influence the environment of tumor cell. These microbiotas have the role in modifying the inflammatory and immune response of tumor cell. Use of synbiotics as monotherapy or in combination with other agents can reduce the severity of HCC. However, further studies are required to prove the above statements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME (2009) Probiotics and immunity. J Gastroenterol 44(1):26–46. https://doi.org/10.1007/s00535-008-2296-0

    Article  PubMed  Google Scholar 

  • Bron PA, van Baarlen P, Kleerebezem M (2011) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10(1):66–78. https://doi.org/10.1038/nrmicro2690

    Article  CAS  PubMed  Google Scholar 

  • Cencic A, Chingwaru W (2010) The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients 2(6):611–625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cerf-Bensussan N, Gaboriau-Routhiau V (2010) The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10(10):735–744

    Article  CAS  PubMed  Google Scholar 

  • Christie JA, Andrea SG (2021) Therapeutic potential of different probiotic foods. In: Advances in probiotics. Academic Press, pp 449–477

    Chapter  Google Scholar 

  • de LeBlanc ADM, Perdigón G (2010) The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 69(3):421–428

    Article  Google Scholar 

  • Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D (2008) Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10(1–2):37–54

    CAS  PubMed  Google Scholar 

  • Delzenne NM, Cani PD (2011) Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31:15–31

    Article  CAS  PubMed  Google Scholar 

  • Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325–2340

    Article  Google Scholar 

  • Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T (2013) Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One 8(5):e63388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Erejuwa OO, Sulaiman SA, Ab Wahab MS (2014) Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int J Mol Sci 15(3):4158–4188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23(11):1953–1960

    Article  CAS  PubMed  Google Scholar 

  • Feyisetan O, Tracey C, Hellawell GO (2012) Probiotics, dendritic cells and bladder cancer. BJU Int 109(11):1594–1597

    Article  CAS  PubMed  Google Scholar 

  • Flint HJ (2012) The impact of nutrition on the human microbiome. Nutr Rev 70(suppl_1):S10–S13

    Article  PubMed  Google Scholar 

  • Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412

    Article  CAS  PubMed  Google Scholar 

  • Gowthaman U, Chen JS, Eisenbarth SC, Zhang B, Flynn WF, Lu Y, Song W et al (2019) Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science 365(6456):eaaw6433. https://doi.org/10.1126/science.aaw6433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361(9356):512–519

    Article  PubMed  Google Scholar 

  • Gulzar N, Saleem IM, Rafiq S, Nadeem M (2019) Therapeutic potential of probiotics and prebiotics. In: Oral health by using probiotic products. Intechopen, London. 10.5772/intechopen.86762

    Google Scholar 

  • Harish K, Varghese T (2006) Probiotics in humans–evidence based review. Calicut Med J 4(4):e3

    Google Scholar 

  • Hernández-Ceballos W, Cordova-Gallardo J, Mendez-Sanchez N (2021) Gut microbiota in metabolic-associated fatty liver disease and in other chronic metabolic diseases. J Clin Transl Hepatol 9(2):227

    PubMed  PubMed Central  Google Scholar 

  • Kamada N, Seo SU, Chen GY, Núñez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13(5):321–335. https://doi.org/10.1038/nri3430

    Article  CAS  PubMed  Google Scholar 

  • Kaur N, Gupta AK (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27(7):703–714

    Article  CAS  PubMed  Google Scholar 

  • Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M (2012) The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol 12(10):728–734. https://doi.org/10.1038/nri3312

    Article  CAS  PubMed  Google Scholar 

  • Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156:477–491

    Article  PubMed  Google Scholar 

  • Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A et al (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107(5):2159–2164. https://doi.org/10.1073/pnas.0904055107

    Article  PubMed  PubMed Central  Google Scholar 

  • Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP (2010) Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31(2):46–251

    Google Scholar 

  • Liong MT, Dunshea FR, Shah NP (2007) Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high-and low-fat diets. Br J Nutr 98(4):736–744

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Sun M, Yao H, Liu Y, Gao R (2017) Herbal medicine for the treatment of obesity: an overview of scientific evidence from 2007 to 2017. Evid Based Complement Alternat Med 8943059:1

    Google Scholar 

  • Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, Chen W (2020) Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact 19(1):1–11

    Article  Google Scholar 

  • Masood MI, Qadir MI, Shirazi JH, Khan IU (2011) Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol 37(1):91–98. https://doi.org/10.3109/1040841X.2010.536522

    Article  PubMed  Google Scholar 

  • Moro TMA, Celegatti CM, Pereira APA, Lopes AS, Barbin DF, Pastore GM, Clerici MTPS (2018) Use of burdock root flour as a prebiotic ingredient in cookies. LWT 90:540–546

    Article  CAS  Google Scholar 

  • Noah TK, Knoop KA, McDonald KG, Gustafsson JK, Waggoner L, Vanoni S et al (2019) IL-13-induced intestinal secretory epithelial cell antigen passages are required for IgE-mediated food-induced anaphylaxis. J Allergy Clin Immunol 144(4):1058–73.e3. https://doi.org/10.1016/j.jaci.2019.04.030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL (2004) Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br J Nutr 91(6):925–932

    Article  CAS  PubMed  Google Scholar 

  • Panda AK, Rao SVR, Raju MV, Sharma SR (2006) Dietary supplementation of Lactobacillus sporogenes on performance and serum biochemico-lipid profile of broiler chickens. J Poultry Sci 43(3):235–240

    Article  CAS  Google Scholar 

  • Parnell JA, Raman M, Rioux KP, Reimer RA (2012) The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int 32(5):701–711

    Article  CAS  PubMed  Google Scholar 

  • Peña AS (2007) Intestinal flora, probiotics, prebiotics, synbiotics and novel foods. Rev Esp Enferm Dig 99(11):653

    PubMed  Google Scholar 

  • Pokusaeva K, Fitzgerald GF, van Sinderen D (2011) Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6(3):285–306

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Russo E, Fiorindi C, Giudici F, Amedei A (2022) Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma. World J Hepatol 14(2):372–385. https://doi.org/10.4254/wjh.v14.i2.372

    Article  PubMed  PubMed Central  Google Scholar 

  • Saulnier DM, Spinler JK, Gibson GR, Versalovic J (2009) Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 20(2):135–141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5(4):1417–1435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Soriano G, Sánchez E, Guarner C (2013) Probiotics in liver diseases. Nutr Hosp 28(3):558–563

    PubMed  Google Scholar 

  • Štofilová J, Szabadosová V, Hrčková G, Salaj R, Bertková I, Hijová E, Strojný L, Bomba A (2015) Co-administration of a probiotic strain Lactobacillus plantarum LS/07 CCM7766 with prebiotic inulin alleviates the intestinal inflammation in rats exposed to N,N-dimethylhydrazine. Int Immunopharmacol 24(2):361–368

    Article  PubMed  Google Scholar 

  • Tajiri K, Shimizu Y (2017) Gut bacteria may control development of hepatocellular carcinoma. Hepatobiliary Surg Nutr 6(6):417

    Article  PubMed  PubMed Central  Google Scholar 

  • Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R et al (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93(2–3):97–108

    Article  CAS  PubMed  Google Scholar 

  • Vrese MD, Schrezenmeir AJ (2008) Probiotics, prebiotics, and synbiotics. Food Biotechnol 111:1–66

    Article  Google Scholar 

  • Wan ML, El-Nezami H (2018) Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy. Hepatobiliary Surg Nutr 7(1):11

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang S, Zhu H, Lu C, Kang Z, Luo Y, Feng L et al (2012) Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals. J Dairy Sci 95(9):4813–4822. https://doi.org/10.3168/jds.2012-5426

    Article  CAS  PubMed  Google Scholar 

  • Webb GP (2011) Dietary supplements and functional foods. John Wiley & Sons

    Book  Google Scholar 

  • Weese JS (2002) Probiotics, prebiotics, and synbiotics. J Equine Vet Sci 22(8):357–360

    Article  Google Scholar 

  • Worbs T, Hammerschmidt SI, Förster R (2017) Dendritic cell migration in health and disease. Nat Rev Immunol 17(1):30–48. https://doi.org/10.1038/nri.2016.116

    Article  CAS  PubMed  Google Scholar 

  • Yamazaki K, Tsunoda AKIRA, Sibusawa MIKI, Tsunoda YUKO, Kusano M, Fukuchi K, Yamanaka M, Kushima M, Nomoto K, Morotomi M (2000) The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep 7(5):977–1059

    CAS  PubMed  Google Scholar 

  • Yiu JH, Dorweiler B, Woo CW (2017) Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. J Mol Med (Berlin, Germany) 95:13–20

    Article  CAS  Google Scholar 

  • Yoo JY, Kim SS (2016) Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients 8(3):173

    Article  PubMed  PubMed Central  Google Scholar 

  • Yu W, DMH F, Nadeau KC (2016) Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol 16(12):751–765. https://doi.org/10.1038/nri.2016.111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zeng H, Chen P, Chen C, Huang C, Lin S, Zheng B, Zhang Y (2018) Structural properties and prebiotic activities of fractionated lotus seed resistant starches. Food Chem 251:33–40

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India

    Kuttiappan Anitha & Jamal Basha Dudekula

  2. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia

    Kamal Dua

  3. School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India

    Shvetank Bhatt

  4. Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, Madhya Pradesh, India

    Neeraj Mishra

Authors
  1. Kuttiappan Anitha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jamal Basha Dudekula
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neeraj Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kamal Dua
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shvetank Bhatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, Madhya Pradesh, India

    Neeraj Mishra

  2. School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India

    Shvetank Bhatt

  3. Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia

    Keshav Raj Paudel

  4. Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia

    Philip M Hansbro

  5. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia

    Kamal Dua

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Anitha, K., Dudekula, J.B., Mishra, N., Dua, K., Bhatt, S. (2023). Synbiotics in Hepatocellular Carcinoma. In: Mishra, N., Bhatt, S., Paudel, K.R., M Hansbro, P., Dua, K. (eds) Synbiotics for the Management of Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-19-7550-9_8

Download citation

Publish with us

Policies and ethics

Search

Navigation